PDB Short entry for 1AVG HEADER COMPLEX (BLOOD COAGULATION/INHIBITOR) 16-SEP-97 1AVG TITLE THROMBIN INHIBITOR FROM TRIATOMA PALLIDIPENNIS COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN; COMPND 3 CHAIN: L; COMPND 4 EC: 3.4.21.5; COMPND 5 OTHER_DETAILS: THE C-TERMINAL SEGMENT OF THE L-CHAIN OF ONE THROMBIN COMPND 6 MOLECULE IS INSERTED IN THE ACTIVE SITE OF A NEIGHBORING THROMBIN COMPND 7 MOLECULE; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: THROMBIN; COMPND 10 CHAIN: H; COMPND 11 EC: 3.4.21.5; COMPND 12 OTHER_DETAILS: THE C-TERMINAL SEGMENT OF THE L-CHAIN OF ONE THROMBIN COMPND 13 MOLECULE IS INSERTED IN THE ACTIVE SITE OF A NEIGHBORING THROMBIN COMPND 14 MOLECULE; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: TRIABIN; COMPND 17 CHAIN: I; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 ORGAN: BLOOD; SOURCE 6 TISSUE: BLOOD; SOURCE 7 SECRETION: BLOOD; SOURCE 8 OTHER_DETAILS: BOVINE THROMBIN WAS PURIFIED FROM FROM FRESH OX BLOOD SOURCE 9 ACCORDING TO REPORTED PROTOCOLS; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 12 ORGANISM_COMMON: CATTLE; SOURCE 13 ORGANISM_TAXID: 9913; SOURCE 14 ORGAN: BLOOD; SOURCE 15 TISSUE: BLOOD; SOURCE 16 SECRETION: BLOOD; SOURCE 17 OTHER_DETAILS: BOVINE THROMBIN WAS PURIFIED FROM FROM FRESH OX BLOOD SOURCE 18 ACCORDING TO REPORTED PROTOCOLS; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: TRIATOMA PALLIDIPENNIS; SOURCE 21 ORGANISM_TAXID: 30077; SOURCE 22 ORGAN: BLOOD; SOURCE 23 EXPRESSION_SYSTEM: INSECT CELLS; SOURCE 24 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS BOVINE THROMBIN, THROMBIN INHIBITOR, COMPLEX (BLOOD COAGULATION- KEYWDS 2 INHIBITOR), COMPLEX (BLOOD COAGULATION-INHIBITOR) COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.FUENTES-PRIOR,R.HUBER,W.BODE REVDAT 4 03-APR-24 1AVG 1 REMARK SEQADV REVDAT 3 24-FEB-09 1AVG 1 VERSN REVDAT 2 16-FEB-99 1AVG 1 SOURCE COMPND REMARK DBREF REVDAT 2 2 1 KEYWDS HEADER REVDAT 1 30-DEC-98 1AVG 0 JRNL AUTH P.FUENTES-PRIOR,C.NOESKE-JUNGBLUT,P.DONNER,W.D.SCHLEUNING, JRNL AUTH 2 R.HUBER,W.BODE JRNL TITL STRUCTURE OF THE THROMBIN COMPLEX WITH TRIABIN, A JRNL TITL 2 LIPOCALIN-LIKE EXOSITE-BINDING INHIBITOR DERIVED FROM A JRNL TITL 3 TRIATOMINE BUG. JRNL REF PROC.NATL.ACAD.SCI.USA V. 94 11845 1997 JRNL REFN ISSN 0027-8424 JRNL PMID 9342325 JRNL DOI 10.1073/PNAS.94.22.11845 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.842 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 14627 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3559 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 171 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.490 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.92 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1AVG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171306. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUN-96 REMARK 200 TEMPERATURE (KELVIN) : 280 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, ROTAVATA, AGROVATA REMARK 200 DATA SCALING SOFTWARE : CCP4 (AGROVATA, ROTAVATA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16392 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 19.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : 0.11200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.2200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.12100 REMARK 200 R SYM FOR SHELL (I) : 0.14800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.650 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: BOVINE THROMBIN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM NA ACETATE, PH 4.6, 100 MM REMARK 280 (NH4)2SO4, 16 % PEG 4,000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.42000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 91.74500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.61500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 91.74500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.42000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.61500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ARG 15 A IS INSERTED IN THE ACTIVE SITE OF A NEIGHBORING REMARK 400 MOLECULE. REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 SER I 47 REMARK 475 LYS I 48 REMARK 475 ASN I 74 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS H 236 CG CD REMARK 480 LEU H 245 CG CD1 CD2 REMARK 480 SER H 247 N CA C O CB OG REMARK 480 LYS I 16 CG CD CE NZ REMARK 480 SER I 45 OG REMARK 480 LYS I 75 C O CG CD CE NZ REMARK 480 ASN I 76 CB CG OD1 ND2 REMARK 480 SER I 86 OG REMARK 480 GLN I 118 CB CG CD OE1 NE2 REMARK 480 LYS I 139 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU H 105 CA - CB - CG ANGL. DEV. = 15.0 DEGREES REMARK 500 SER H 195 N - CA - C ANGL. DEV. = 17.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN L 1K -122.56 -75.59 REMARK 500 GLU L 1J -25.59 -171.18 REMARK 500 PHE L 7 -83.23 -125.12 REMARK 500 GLU L 14L 99.24 46.10 REMARK 500 PRO H 28 1.51 -62.00 REMARK 500 TYR H 60A 79.92 -163.83 REMARK 500 ASN H 60G 66.39 -161.87 REMARK 500 HIS H 71 -53.93 -138.80 REMARK 500 GLU H 97A -97.86 -89.43 REMARK 500 SER H 115 -159.36 -160.27 REMARK 500 SER H 195 3.34 -41.04 REMARK 500 LEU H 245 94.97 -174.88 REMARK 500 GLU I 2 106.34 -54.33 REMARK 500 ASP I 14 20.43 -73.42 REMARK 500 VAL I 33 130.15 -35.73 REMARK 500 SER I 45 85.93 -67.63 REMARK 500 SER I 47 47.44 -88.35 REMARK 500 LYS I 48 -82.29 59.57 REMARK 500 PHE I 50 85.09 -65.21 REMARK 500 ASN I 64 43.71 -109.81 REMARK 500 GLU I 91 132.87 70.56 REMARK 500 TYR I 103 -8.72 -47.89 REMARK 500 ASN I 105 -79.77 -131.60 REMARK 500 SER I 117 -95.79 -72.89 REMARK 500 LYS I 120 114.26 68.24 REMARK 500 GLU I 121 112.77 -164.43 REMARK 500 ASP I 133 -69.08 51.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ATE REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC TRIAD. DBREF 1AVG L 1 15 UNP P00735 THRB_BOVIN 326 366 DBREF 1AVG H 16 247 UNP P00735 THRB_BOVIN 367 625 DBREF 1AVG I 1 142 UNP Q27049 TRIA_TRIPA 19 160 SEQADV 1AVG ARG I 123 UNP Q27049 ASP 141 CONFLICT SEQADV 1AVG PHE I 127 UNP Q27049 LEU 145 CONFLICT SEQRES 1 L 41 PHE PHE ASN GLU LYS THR PHE GLY ALA GLY GLU ALA ASP SEQRES 2 L 41 CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS GLN VAL GLN SEQRES 3 L 41 ASP GLN THR GLU LYS GLU LEU PHE GLU SER TYR ILE GLU SEQRES 4 L 41 GLY ARG SEQRES 1 H 259 ILE VAL GLU GLY GLN ASP ALA GLU VAL GLY LEU SER PRO SEQRES 2 H 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 H 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 H 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 H 259 ASN PHE THR VAL ASP ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 H 259 HIS SER ARG THR ARG TYR GLU ARG LYS VAL GLU LYS ILE SEQRES 7 H 259 SER MET LEU ASP LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 H 259 TRP LYS GLU ASN LEU ASP ARG ASP ILE ALA LEU LEU LYS SEQRES 9 H 259 LEU LYS ARG PRO ILE GLU LEU SER ASP TYR ILE HIS PRO SEQRES 10 H 259 VAL CYS LEU PRO ASP LYS GLN THR ALA ALA LYS LEU LEU SEQRES 11 H 259 HIS ALA GLY PHE LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 H 259 ARG ARG GLU THR TRP THR THR SER VAL ALA GLU VAL GLN SEQRES 13 H 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO LEU VAL GLU SEQRES 14 H 259 ARG PRO VAL CYS LYS ALA SER THR ARG ILE ARG ILE THR SEQRES 15 H 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO GLY GLU GLY SEQRES 16 H 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 H 259 PHE VAL MET LYS SER PRO TYR ASN ASN ARG TRP TYR GLN SEQRES 18 H 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 H 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 H 259 LYS TRP ILE GLN LYS VAL ILE ASP ARG LEU GLY SER SEQRES 1 I 142 ALA GLU GLY ASP ASP CYS SER ILE GLU LYS ALA MET GLY SEQRES 2 I 142 ASP PHE LYS PRO GLU GLU PHE PHE ASN GLY THR TRP TYR SEQRES 3 I 142 LEU ALA HIS GLY PRO GLY VAL THR SER PRO ALA VAL CYS SEQRES 4 I 142 GLN LYS PHE THR THR SER GLY SER LYS GLY PHE THR GLN SEQRES 5 I 142 ILE VAL GLU ILE GLY TYR ASN LYS PHE GLU SER ASN VAL SEQRES 6 I 142 LYS PHE GLN CYS ASN GLN VAL ASP ASN LYS ASN GLY GLU SEQRES 7 I 142 GLN TYR SER PHE LYS CYS LYS SER SER ASP ASN THR GLU SEQRES 8 I 142 PHE GLU ALA ASP PHE THR PHE ILE SER VAL SER TYR ASP SEQRES 9 I 142 ASN PHE ALA LEU VAL CYS ARG SER ILE THR PHE THR SER SEQRES 10 I 142 GLN PRO LYS GLU ASP ARG TYR LEU VAL PHE GLU ARG THR SEQRES 11 I 142 LYS SER ASP THR ASP PRO ASP ALA LYS GLU ILE CYS FORMUL 4 HOH *171(H2 O) HELIX 1 1 GLU L 1C ASP L 1A 5 3 HELIX 2 2 GLU L 8 LYS L 10 5 3 HELIX 3 3 GLU L 14C TYR L 14J 1 8 HELIX 4 4 ALA H 56 CYS H 58 5 3 HELIX 5 5 PRO H 60B TRP H 60D 5 3 HELIX 6 6 LYS H 126 LEU H 129C 1 7 HELIX 7 7 VAL H 149C GLU H 149E 5 3 HELIX 8 8 ARG H 165 ALA H 170 1 6 HELIX 9 9 PHE H 232 ILE H 242 5 11 HELIX 10 10 CYS I 6 ILE I 8 5 3 HELIX 11 11 PRO I 17 PHE I 20 1 4 SHEET 1 A 4 LYS H 81 SER H 83 0 SHEET 2 A 4 LEU H 64 ILE H 68 -1 N ILE H 68 O LYS H 81 SHEET 3 A 4 GLN H 30 ARG H 35 -1 N PHE H 34 O LEU H 65 SHEET 4 A 4 GLU H 39 SER H 45 -1 N ALA H 44 O VAL H 31 SHEET 1 B 3 TRP H 51 THR H 54 0 SHEET 2 B 3 ALA H 104 LEU H 108 -1 N LEU H 106 O VAL H 52 SHEET 3 B 3 LEU H 85 ILE H 90 -1 N TYR H 89 O LEU H 105 SHEET 1 C 2 LYS H 135 GLY H 140 0 SHEET 2 C 2 GLN H 156 PRO H 161 -1 N LEU H 160 O GLY H 136 SHEET 1 D 4 MET H 180 ALA H 183 0 SHEET 2 D 4 GLY H 226 HIS H 230 -1 N TYR H 228 O PHE H 181 SHEET 3 D 4 TRP H 207 TRP H 215 -1 N TRP H 215 O PHE H 227 SHEET 4 D 4 PRO H 198 LYS H 202 -1 N MET H 201 O TYR H 208 SHEET 1 E 8 THR I 24 ALA I 28 0 SHEET 2 E 8 THR I 51 ILE I 56 1 N GLN I 52 O TRP I 25 SHEET 3 E 8 ALA I 37 THR I 43 -1 N PHE I 42 O THR I 51 SHEET 4 E 8 LYS I 66 GLN I 71 1 N PHE I 67 O CYS I 39 SHEET 5 E 8 TYR I 80 SER I 86 -1 N LYS I 85 O GLN I 68 SHEET 6 E 8 PHE I 92 VAL I 101 -1 N PHE I 96 O TYR I 80 SHEET 7 E 8 PHE I 106 PHE I 115 -1 N THR I 114 O GLU I 93 SHEET 8 E 8 ASP I 122 GLU I 128 -1 N PHE I 127 O ALA I 107 SSBOND 1 CYS L 1 CYS H 122 1555 1555 2.03 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.04 SSBOND 3 CYS H 168 CYS H 182 1555 1555 2.03 SSBOND 4 CYS H 191 CYS H 220 1555 1555 2.02 SSBOND 5 CYS I 6 CYS I 110 1555 1555 2.03 SSBOND 6 CYS I 39 CYS I 142 1555 1555 2.03 SSBOND 7 CYS I 69 CYS I 84 1555 1555 2.02 CISPEP 1 SER H 36A PRO H 37 0 0.06 CISPEP 2 SER I 35 PRO I 36 0 -0.31 SITE 1 ATE 3 SER H 195 HIS H 57 ASP H 102 CRYST1 44.840 67.230 183.490 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022302 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014874 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005450 0.00000